• Advancing non-hormonal contraceptive research

    Nuvisan receives US$25 million grant from the Gates Foundation to help bring novel non-hormonal contraceptives to life.

    Read more
    Immunostaining of subcellular featuresImmunostaining of subcellular features
Cancer cell structure under a microscope, showing mutation, oncology research, and malignant tumor development

Discovery

Helping you to achieve key decision milestones through deep scientific insights, innovation and collaboration.

Learn More
Red blood cells flowing in a vessel 

Preclinical

Enabling you to successfully develop and de-risk your preclinical candidates for a smooth transition to the clinic.

Learn More
A group of medical professionals in white coats and scrubs, with a close-up focus on a female doctor crossing her arms.

Clinical

Providing tailored clinical solutions to fully assess your drug faster.

Learn More
Scientist wearing gloves holding pills in a laboratory setting

CMC

Collaborating with you to advance molecules into drug products.

Learn More
Futuristic DNA data storage visualization with binary code on high-tech blue background

Digital

Empowering your drug discovery and development with integrated data services, machine learning and generative AI.

Learn More

Research phases

Supporting you with integrated, tailored solutions at every step of your drug discovery and development journey.

Visual highlighting our solutions 

Nuvisan is the unique CRO/CDMO with extensive pharma experience and industry-leading scientific expertise, providing highest-quality end-to-end solutions. From enabling target understanding to helping get innovative medicines to the patients who need them, we provide support that streamlines and accelerates drug discovery and development.

Our science

News and events